Literature DB >> 24097051

Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry.

Meghan J Walker1, Lucia Mirea, Kristine Cooper, Mitra Nabavi, Gord Glendon, Irene L Andrulis, Julia A Knight, Frances P O'Malley, Anna M Chiarelli.   

Abstract

Although several studies have found screen-detected cancers in women with familial breast cancer risk have favorable prognostic features compared with symptomatic cancers, the impact of level of familial risk is unknown. A cohort of 899 first-degree female relatives of cases of breast cancer from the Ontario site of the Breast Cancer Family Registry was followed for 2 years. Logistic regression analyses compared diagnoses of breast cancer or benign breast disease (BBD) between women at high (n = 258, 28.7 %) versus low/moderate (n = 641, 71.3 %) familial risk. Similar analyses compared prognostic features of invasive cancers and BBD by level of familial risk and mammography screening status. Among 899 women, 44 (4.9 %) were diagnosed with invasive breast cancer and/or ductal carcinoma in situ, and 56 (6.2 %) with BBD. Women with high familial risk were significantly more likely to be diagnosed with breast cancer [odds ratio (OR) = 2.84, 95 % confidence interval (CI) 1.50-5.38] than low/moderate risk women, particularly if diagnosed at age ≥50 (OR = 2.99, 95 % CI 1.37-6.56) or screened with mammography (OR = 3.33, 95 % CI 1.54-7.18). High risk women were more likely to be diagnosed with BBD (OR = 1.94, 95 % CI 1.03-3.66). Level of familial risk was not associated with prognostic features. Cancers among unscreened women were larger (OR = 9.72, 95 % CI 1.01-93.61) and diagnosed at stage II or above (OR = 7.80, 95 % CI 1.18-51.50) compared with screen-detected cancers. Screening mammography may be effective for women with a first-degree family history of breast cancer, irrespective of level of familial risk.

Entities:  

Mesh:

Year:  2014        PMID: 24097051     DOI: 10.1007/s10689-013-9689-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  74 in total

Review 1.  Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.

Authors:  Anna M Chiarelli; Sarah A Edwards; Amanda J Sheppard; Lucia Mirea; Nelson Chong; Lawrence Paszat; Rene S Shumak; Frances P Oʼmalley
Journal:  Eur J Cancer Prev       Date:  2012-11       Impact factor: 2.497

2.  Assessing the effectiveness of a mammography screening service.

Authors:  Cassandra Clayforth; Lin Fritschi; Suzanne McEvoy; Michael J Byrne; Elizabeth Wylie; Tim Threlfall; Greg Sterrett; Jennet M Harvey; Konrad Jamrozik
Journal:  ANZ J Surg       Date:  2005-08       Impact factor: 1.872

Review 3.  Benign breast diseases, carcinoma in situ, and breast cancer risk.

Authors:  C A Bodian
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  Family history of breast cancer in relation to tumor characteristics and mortality in a population-based study of young women with invasive breast cancer.

Authors:  Kathleen E Malone; Janet R Daling; David R Doody; Cecilia O'Brien; Alexa Resler; Elaine A Ostrander; Peggy L Porter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-29       Impact factor: 4.254

5.  An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia.

Authors:  H Pastides; J L Kelsey; T R Holford; V A LiVolsi
Journal:  Am J Epidemiol       Date:  1985-03       Impact factor: 4.897

6.  Jewish religion and risk of breast cancer.

Authors:  K M Egan; P A Newcomb; M P Longnecker; A Trentham-Dietz; J A Baron; D Trichopoulos; M J Stampfer; W C Willett
Journal:  Lancet       Date:  1996-06-15       Impact factor: 79.321

7.  Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer.

Authors:  E E Halapy; A M Chiarelli; N Klar; J Knight
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

8.  Risk factors for fibrocystic breast disease and its histopathologic components.

Authors:  G S Berkowitz; J L Kelsey; V A LiVolsi; T R Holford; M J Merino; S Ort; T Z O'Connor; C White
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

9.  The significance of family history for patients with carcinoma of the breast.

Authors:  D Israeli; P I Tartter; S T Brower; B Mizrachy; J Bratton
Journal:  J Am Coll Surg       Date:  1994-07       Impact factor: 6.113

10.  Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.

Authors: 
Journal:  Lancet Oncol       Date:  2010-11-17       Impact factor: 41.316

View more
  2 in total

1.  Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry.

Authors:  Meghan J Walker; Lucia Mirea; Gord Glendon; Paul Ritvo; Irene L Andrulis; Julia A Knight; Anna M Chiarelli
Journal:  Breast       Date:  2014-05-10       Impact factor: 4.380

2.  Disparities in Breast Cancer Survivors in Rural West Texas.

Authors:  Hafiz Khan; Drew Rasmussen; Kemesha Gabbidon; Komaraiah Palle; Aamrin Rafiq; Mohammad Faysel; Sharda Singh; P Hemachandra Reddy
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.